APA (7th ed.) Citation

RL, R., MC, A., SH, A., RD, B., PA, F., E, G., . . . JE, S. (2025). Biomarker-driven drug development for allergic diseases and asthma: An FDA public workshop. The Journal of allergy and clinical immunology, 155(6), 1753. https://doi.org/10.1016/j.jaci.2025.03.014

Chicago Style (17th ed.) Citation

RL, Rabin, et al. "Biomarker-driven Drug Development for Allergic Diseases and Asthma: An FDA Public Workshop." The Journal of Allergy and Clinical Immunology 155, no. 6 (2025): 1753. https://doi.org/10.1016/j.jaci.2025.03.014.

MLA (9th ed.) Citation

RL, Rabin, et al. "Biomarker-driven Drug Development for Allergic Diseases and Asthma: An FDA Public Workshop." The Journal of Allergy and Clinical Immunology, vol. 155, no. 6, 2025, p. 1753, https://doi.org/10.1016/j.jaci.2025.03.014.